Efficacy and safety of generic and original pioglitazone in type 2 diabetes mellitus: A multicenter, a double-blinded, randomized-controlled study

• Main Authors: Petch Rawdaree, Chaicharn Deerochanawong, Thavatchai Peerapatdit, Nuntakorn Thongtang, Sompongse Suwanwalaikorn, Ampai Khemkha, Yupin Benjasuratwong, Apussanee Boonyavarakul, Thanya Chetthakul, Rattana Leelawattana, Chardpraorn Ngarmukos, Chukiat Viwatwongkasem, Thongchai Pratipanawatr, Natapong Kosachunhanun
• Format: Journal
• Published: 2018
• Subjects: Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=78649246535&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/51034
• Institution: Chiang Mai University

Objective: To compare the efficacy and safety of generic (Utmos®) and original (Actos®) 30 mg Pioglitazone tablets. Study design: A multicenter, parallel randomized, double-blinded, controlled study. Material and Method: Type 2 diabetic patients, with glycosylated hemoglobin (HbA1c) ≥ 7.0%, who rece...